Business
PRTC Adds Industry Leader to Board of Directors
PRTC Adds Industry Leader to Board of Directors.
About this update from Puretech Health Plc
[{"type":"text","content":"\n\n22 August 2024\nPureTech Health plc\n \nPureTech Appoints Michele Holcomb, PhD, to Board of Directors\n \nStrategic healthcare leader brings more than 30 years of global experience to PureTech's Board following notable positions with Cardinal Health, Teva Pharmaceuticals and McKinsey & Company\n \nPureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb's appointment will take effect as of September 23, 2024. She brings more than 30 years of expertise leading global healthcare companies through strategic inflection points and preparing innovative programs and portfolios for growth.\n \n\"As PureTech enters its next phase of growth focused on innovating and progressing major advances for patients, Dr. Holcomb brings a wealth of experience to our strategy that's built among highly visible healthcare organizations,\" said Bharatt Chowrira, PhD, JD, Chief Executive Officer of PureTech. \"She has a proven track record of leading transformational growth initiatives and driving organizational progress that will complement our board's exceptional leadership, and we will greatly benefit from Dr. Holcomb's broad biopharma experience as we deliver on our commitment to bring highly innovative and differentiated new medicines to patients and build value for all of our shareholders.\"\n \n\"PureTech pioneered the hub-and-spoke business model, and its approach successfully combines commercial, scientific and medical expertise towards a highly focused development strategy for each of the therapies in its portfolio,\" commented Dr. Holcomb. \"I am excited and honored to work with my fellow board members and the PureTech management team to guide the Company through the next stage of evolution.\"\n \nDr. Holcomb is a strategic leader with more than 30 years of healthcare experience across biotech, pharmaceuticals and healthcare services. She has served on both public and private boards, and has been a scientist, consultant and executive, driving change through innovation and optimization at key interfaces. In her previous role as EVP, Chief Str...